| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy;
Biological Sciences, Imperial College London, London, United Kingdom;
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461; and
Department of Microbiology and Immunology, University of Nevada, Reno, NV 89557
The major component of capsular material of Cryptococcus neoformans is glucuronoxylomannnan (GXM), a polysaccharide that exhibits potent immunosuppressive properties in vitro and in vivo. The results reported here show that 1) soluble purified GXM induces a prompt, long-lasting, and potent up-regulation of Fas ligand (FasL) on macrophages, 2) the up-regulation of FasL is related to induced synthesis and increased mobilization to the cellular surface, 3) this effect is largely mediated by interaction between GXM and TLR4, 4) FasL up-regulation occurs exclusively in GXM-loaded macrophages, 5) macrophages that show up-regulation of FasL induce apoptosis of activated T cells expressing Fas and Jurkat cells that constitutively express Fas, and 6) anti-Fas Abs rescue T cells from apoptosis induced by GXM. Collectively our results reveal novel aspects of the immunoregulatory properties of GXM and suggest that this nontoxic soluble compound could be used to dampen the immune response, to promote or accelerate the death receptor, and to fix FasL expression in a TLR/ligand-dependent manner. In the present study, we delineate potential new therapeutic applications for GXM that exploit death receptors as key molecular targets in regulating cell-mediated cytotoxicity, immune homeostasis, and the immunopathology of diseases.
This article has been cited by other articles:
|
|
 |
|
  G. M. Olson, D. S. Fox, P. Wang, J. A. Alspaugh, and K. L. Buchanan Role of Protein O-Mannosyltransferase Pmt4 in the Morphogenesis and Virulence of Cryptococcus neoformans Eukaryot. Cell, February 1, 2007; 6(2): 222 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Barbosa, F. L. Fonseca, R. T. Figueiredo, M. T. Bozza, A. Casadevall, L. Nimrichter, and M. L. Rodrigues Binding of Glucuronoxylomannan to the CD14 Receptor in Human A549 Alveolar Cells Induces Interleukin-8 Production Clin. Vaccine Immunol., January 1, 2007; 14(1): 94 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Monari, T. R. Kozel, F. Paganelli, E. Pericolini, S. Perito, F. Bistoni, A. Casadevall, and A. Vecchiarelli Microbial Immune Suppression Mediated by Direct Engagement of Inhibitory Fc Receptor J. Immunol., November 15, 2006; 177(10): 6842 - 6851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. McFadden, M. De Jesus, and A. Casadevall The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction J. Biol. Chem., January 27, 2006; 281(4): 1868 - 1875. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
